MedPath

Frozen Red Blood Cell Transfusions in Trauma Patients

Not Applicable
Completed
Conditions
Blood Loss
Anemia
Trauma
Interventions
Biological: RBC units
Registration Number
NCT01038557
Lead Sponsor
Oregon Health and Science University
Brief Summary

The purpose of this study is to look at red blood cell (RBC) transfusions in trauma patients and evaluate for any differences between the age of the RBCs and how they were stored. The investigators will specifically look for the following differences between study groups:

1. the transfused red blood cells' ability to delivery oxygen to the tissues

2. differences in biochemical markers in subjects and units transfused, and

3. how the subject's internal organs are working and if they develop any infections

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
254
Inclusion Criteria
  • Trauma Service with an Injury Severity Score > 4
  • Require a blood (PRBC) transfusion
  • Transfusion is not emergent
  • Able to obtain consent from patient or appropriate 3rd party prior to 1st transfusion
Exclusion Criteria
  • Inability to adhere to blood age randomization due to limitations of the blood bank inventory
  • Bilateral hand injuries that prevent StO2 measurements
  • Age < 15
  • Pregnancy
  • Massive transfusion (=/> 10 units in 24 hours) in last 3 months
  • Hemodynamically unstable or need for transfusion in < 3 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Refrigerated RBCs 15-42 days oldRBC unitsStandard, refrigerated RBC units stored 15-42 days
Refrigerated RBCs 0-14 days oldRBC unitsStandard, refrigerated RBC units stored up to 14 days
Frozen RBCsRBC unitsRBC units stored frozen at -80 degrees Celsius, then thawed and deglycerolized using the ACP 215.
Primary Outcome Measures
NameTimeMethod
Tissue OxygenationPercentage of baseline (3 hours post transfusion compared to baseline)

Assessment of tissue oxygenation by NIRS in subjects up to 3 hours after PRBC transfusion.

Secondary Outcome Measures
NameTimeMethod
Haptoglobin Levels 12 Hours After Transfusion12 hours after transfusion

Haptoglobin levels after transfusion

Clinical Outcomes - Hospital Daysfrom time of randomization through hospital discharged, assessed up to 6 months

Clinical outcomes - Number of days admitted to the hospital within a 6 month window.

Free Hemoglobin Levels After Transfusion12 hours after transfusion

Free hemoglobin levels 12 hours after transfusion

2,3 DPG Levels After Transfusion12 hours post transfusion

2,3 DPG levels 12 hours after transfusion

Clinical Outcomes - Infectionsfrom time of randomization through hospital discharged, assessed up to 6 months

Number of subjects who developed infections while hospitalized.

Clinical Outcomes - ICU Daysfrom time of randomization through hospital discharged, assessed up to 6 months

Number of days admitted to the ICU during hospital admission

Clinical Outcomes - Ventilator Daysfrom time of randomization through hospital discharged, assessed up to 6 months
Clinical Outcomes - Acute Respiratory Distress Syndromefrom time of randomization through hospital discharged, assessed up to 6 months

Number of subjects who developed acute respiratory distress syndrome while hospitalized.

Number of Participants With Acute Renal Failurefrom time of randomization through hospital discharged, assessed up to 6 months

Number of participants who developed acute renal failure while hospitalized.

Trial Locations

Locations (5)

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath